3SBio Stock

3SBio Dividend 2024

3SBio Dividend

0.1 CNY

3SBio Dividend yield

1.61 %

Ticker

1530.HK

ISIN

KYG8875G1029

WKN

A14T7Q

How much dividend does 3SBio 2024 pay?

According to the latest status from October 2024, 3SBio paid a total of 0.1 CNY per share in dividends within the last 12 months. With the current 3SBio price of 6.2 CNY, this corresponds to a dividend yield of 1.61 %. A dividend is paid times per year.

1.61 % Dividend Yield=
0.1 CNY Dividend
6.2 CNY Stock Price

Historical 3SBio Dividends

A dividend is paid times per year. Last year, the payout months were and July.

PaydateDividend
8/22/20240.25
7/27/20230.1
7/27/20220.2
7/29/20180.07
1

3SBio dividend history and estimates

In 2023, 3SBio paid a dividend amounting to 0.1 CNY. Dividend means that 3SBio distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for 3SBio provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify 3SBio’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating 3SBio's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

3SBio Dividend History

Date3SBio Dividend
2029e0.11 undefined
2028e0.11 undefined
2027e0.11 undefined
2026e0.11 undefined
2025e0.11 undefined
2024e0.11 undefined
20230.1 undefined
20220.2 undefined
20180.07 undefined

Is the 3SBio Dividend Safe?

3SBio has been increasing the dividend for 2 years.

Over the past 10 years, 3SBio has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 7.86%.

Analysts expect a Dividend Increase of 5.401% for the current fiscal year.

3SBio dividend payout ratio

In 2023, 3SBio had a payout ratio of 24.2%. The payout ratio indicates the percentage of the company's profits that 3SBio distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for 3SBio represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for 3SBio could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate 3SBio's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

3SBio Payout Ratio History

Date3SBio Payout ratio
2029e25.22 %
2028e25.34 %
2027e25.29 %
2026e25.02 %
2025e25.71 %
2024e25.15 %
202324.2 %
202227.78 %
202123.48 %
202021.33 %
201921.33 %
201814.89 %
201721.33 %
201621.33 %
201521.33 %
201421.33 %
201321.33 %
201221.33 %
201121.33 %
201021.33 %
200921.33 %
200821.33 %
200721.33 %
200621.33 %
200521.33 %
200421.33 %

Dividend Details

Understanding 3SBio's Dividend Distributions

3SBio’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining 3SBio's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

3SBio's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in 3SBio’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

3SBio Aktienanalyse

What does 3SBio do?

3SBio Inc. is a biopharmaceutical company from China that specializes in the research, development, manufacturing, and marketing of biological products. It was founded in 1993 in Shenyang, a city in northeast China, and its headquarters are now in Beijing. 3SBio's business model is based on the development and manufacturing of biopharmaceuticals that are used to treat cancer, autoimmune diseases, and other serious illnesses. The company focuses on biological medicines such as proteins, antibodies, and peptides that are produced using genetic technology. 3SBio operates a wide range of business sectors, including the manufacturing and sale of biopharmaceutical products, the manufacturing and sale of generics and biosimilar products, and research and development in the biotechnology field. The company also has several subsidiaries and joint ventures, including 3SBio International Holding, Sunshine Guojian Pharmaceutical, and Target Pharma. A well-known product of 3SBio is erythropoietin (EPO), which is used in the treatment of anemia. The company also has a portfolio of other biopharmaceutical products that are used to treat cancer, autoimmune diseases, and other serious illnesses. The history of 3SBio goes back to 1993 when it was founded as Shenyang Sunshine Pharmaceutical. In 2001, the company was renamed "Shenyang Sunshine Pharmaceutical Co. Ltd. 3S Bio" and focused on biological therapy. In 2007, the company successfully listed on the Hong Kong Stock Exchange and received the name 3SBio. In 2013, the company was privatized and acquired by a consortium of Chinese investment companies. 3SBio has a strong presence in China and is also expanding into international markets. The company has distribution partnerships in Asia, Europe, and North America, and plans to enter more markets. Overall, 3SBio is a leading company in China in the field of biopharmaceuticals that focuses on the treatment of serious illnesses. The company aims to be a leader in research and development, as well as in the manufacturing and sale of innovative products, and to expand its presence in global markets. 3SBio is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about 3SBio stock

How much dividend does 3SBio pay?

Over the past 12 months, 3SBio paid a dividend of 0.1 CNY . This corresponds to a dividend yield of about 1.61 %. For the coming 12 months, 3SBio is expected to pay a dividend of 0.11 CNY.

What is the dividend yield of 3SBio?

The current dividend yield of 3SBio is 1.61 %.

When does 3SBio pay dividends?

3SBio pays a quarterly dividend. This is distributed in the months of July, July, July, August.

How secure is the dividend of 3SBio?

3SBio paid dividends every year for the past 0 years.

What is the dividend of 3SBio?

For the upcoming 12 months, dividends amounting to 0.11 CNY are expected. This corresponds to a dividend yield of 1.79 %.

In which sector is 3SBio located?

3SBio is assigned to the 'Health' sector.

Wann musste ich die Aktien von 3SBio kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of 3SBio from 8/5/2024 amounting to 0.25 CNY, you needed to have the stock in your portfolio before the ex-date on 7/22/2024.

When did 3SBio pay the last dividend?

The last dividend was paid out on 8/5/2024.

What was the dividend of 3SBio in the year 2023?

In the year 2023, 3SBio distributed 0.2 CNY as dividends.

In which currency does 3SBio pay out the dividend?

The dividends of 3SBio are distributed in CNY.

Andere Kennzahlen von 3SBio

Our stock analysis for 3SBio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of 3SBio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.